Cellphire, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Nov 16, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Dec 11, 2025 · D | Nov 16, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $3,000,000 | $8,000,000 | $5,000,000 |
| Reported amount sold | $3,000,000 | $6,494,308 | $3,494,308 |
| Reported investor count | — | 22 | — |
| Reported minimum investment | $17,736 | $1,000 | $-16,736 |
Earlier SEC source: 0001815181-25-000002 · Later SEC source: 0001815181-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $8,000,000
- Reported exemptions
- Rule 506(c)
- Reported amount sold
- $6,494,308
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001815181-26-000001D · Nov 16, 2026 · BiotechnologyOffering: $8,000,000Sold: $6,494,308
Compared with 0001815181-25-000002:
- Reported offering amount: $3,000,000 → $8,000,000
- Reported amount sold: $3,000,000 → $6,494,308
- Reported investor count: Unavailable → 22
- Reported minimum investment: $17,736 → $1,000
-
0001815181-25-000002D · Dec 11, 2025 · BiotechnologyOffering: $3,000,000Sold: $3,000,000